Antonio Gnoni - Search Results

Year	Number of Results
2006	1
2007	1
2008	2
2009	3
2010	4
2011	5
2012	4
2013	8
2014	4
2015	8
2016	7
2017	3
2018	2
2019	9
2020	8
2021	2

1

Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?

Gnoni A, Longo S, Gnoni GV, Giudetti AM. Gnoni A, et al. Molecules. 2020 Jan 1;25(1):182. doi: 10.3390/molecules25010182. Molecules. 2020. PMID: 31906370 Free PMC article. Review.

2

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib.

Brunetti O, Gnoni A, Licchetta A, Longo V, Calabrese A, Argentiero A, Delcuratolo S, Solimando AG, Casadei-Gardini A, Silvestris N. Brunetti O, et al. Among authors: gnoni a. Medicina (Kaunas). 2019 Oct 21;55(10):707. doi: 10.3390/medicina55100707. Medicina (Kaunas). 2019. PMID: 31640191 Free PMC article. Review.

3

Immunotherapeutic approaches for hepatocellular carcinoma.

Longo V, Gnoni A, Casadei Gardini A, Pisconti S, Licchetta A, Scartozzi M, Memeo R, Palmieri VO, Aprile G, Santini D, Nardulli P, Silvestris N, Brunetti O. Longo V, et al. Among authors: gnoni a. Oncotarget. 2017 May 16;8(20):33897-33910. doi: 10.18632/oncotarget.15406. Oncotarget. 2017. PMID: 28420805 Free PMC article. Review.

4

Immune system and bone microenvironment: rationale for targeted cancer therapies.

Gnoni A, Brunetti O, Longo V, Calabrese A, Argentiero AL, Calbi R, Solimando Antonio G, Licchetta A. Gnoni A, et al. Oncotarget. 2020 Jan 28;11(4):480-487. doi: 10.18632/oncotarget.27439. eCollection 2020 Jan 28. Oncotarget. 2020. PMID: 32064051 Free PMC article. Review.

5

Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.

Longo V, Brunetti O, Gnoni A, Licchetta A, Delcuratolo S, Memeo R, Solimando AG, Argentiero A. Longo V, et al. Among authors: gnoni a. Medicina (Kaunas). 2019 Oct 17;55(10):698. doi: 10.3390/medicina55100698. Medicina (Kaunas). 2019. PMID: 31627433 Free PMC article. Review.

6

Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue.

Longo V, Brunetti O, Gnoni A, Cascinu S, Gasparini G, Lorusso V, Ribatti D, Silvestris N. Longo V, et al. Among authors: gnoni a. Oncotarget. 2016 Sep 6;7(36):58649-58658. doi: 10.18632/oncotarget.10765. Oncotarget. 2016. PMID: 27462915 Free PMC article. Review.

7

Target therapies in pancreatic carcinoma.

Silvestris N, Gnoni A, Brunetti AE, Vincenti L, Santini D, Tonini G, Merchionne F, Maiello E, Lorusso V, Nardulli P, Azzariti A, Reni M. Silvestris N, et al. Among authors: gnoni a. Curr Med Chem. 2014;21(8):948-65. doi: 10.2174/09298673113209990238. Curr Med Chem. 2014. PMID: 23992319 Review.

8

Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.

Gnoni A, Licchetta A, Scarpa A, Azzariti A, Brunetti AE, Simone G, Nardulli P, Santini D, Aieta M, Delcuratolo S, Silvestris N. Gnoni A, et al. Int J Mol Sci. 2013 Sep 30;14(10):19731-62. doi: 10.3390/ijms141019731. Int J Mol Sci. 2013. PMID: 24084722 Free PMC article. Review.

9

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?

Brunetti O, Russo A, Scarpa A, Santini D, Reni M, Bittoni A, Azzariti A, Aprile G, Delcuratolo S, Signorile M, Gnoni A, Palermo L, Lorusso V, Cascinu S, Silvestris N. Brunetti O, et al. Among authors: gnoni a. Oncotarget. 2015 Sep 15;6(27):23323-41. doi: 10.18632/oncotarget.4492. Oncotarget. 2015. PMID: 26259238 Free PMC article. Review.

10

Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies.

Gnoni A, Licchetta A, Memeo R, Argentiero A, Solimando AG, Longo V, Delcuratolo S, Brunetti O. Gnoni A, et al. Medicina (Kaunas). 2019 Nov 21;55(12):754. doi: 10.3390/medicina55120754. Medicina (Kaunas). 2019. PMID: 31766556 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results